Further analysis revealed that the IGFBP1hiWNT3Alo signature is associated with the good outcome of immunotherapy in both American and Chinese populations with esophageal cancer, and has better predictive efficacy than PD-L1 expression. Here, CD274 is linked to esophageal cancer.